Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 2,255 | 2,997 | 3,373 | 2,481 | 2,889 |
| Cost of Goods | 3,259 | 7,273 | 8,862 | 1,468 | 3,803 |
| Gross Profit | -1,004 | -4,276 | -5,489 | 1,013 | -914 |
| Operating Expenses | 3,522 | 3,714 | 4,390 | 3,472 | 5,753 |
| Operating Income | -4,526 | -7,990 | -9,879 | -2,459 | -6,667 |
| Interest Expense | 0 | 1,019 | 1,531 | 1,229 | 1,196 |
| Other Income | 1,626 | 1,146 | -248 | -15,255 | 2,984 |
| Pre-tax Income | -2,900 | -7,863 | -11,658 | -18,943 | -4,879 |
| Income Tax | N/A | 196 | 0 | N/A | N/A |
| Net Income Continuous | -2,900 | -8,059 | -11,658 | -18,943 | -4,879 |
| Minority Interests | 6 | 194 | 167 | 81 | 145 |
| Net Income | $-2,894 | $-7,865 | $-11,491 | $-18,862 | $-4,734 |
| EPS Basic Total Ops | -0.01 | -0.03 | -0.06 | -0.10 | -0.03 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.06 | -0.10 | -0.03 |
| EPS Diluted Total Ops | -0.01 | -0.03 | -0.06 | -0.10 | -0.03 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.06 | -0.10 | -0.03 |
| EBITDA(a) | $-2,046 | $-5,875 | $-9,006 | $-16,404 | $-2,263 |